Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Shingrix (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) |
| BNF code | 1404000ALBCABAC |
| Virtual Medicinal Product | Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials |
| Name | Shingrix (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials |
| Abbreviated name | Shingrix (Herpes Zoster) adjuvanted rcmb vacc inj 0.5ml |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Shingrix (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.